ASB2 and acute myeloid leukemia: FTO regulates the expression of target genes such as ASB2 and RARA by decreasing the level of m6A, promotes leukemic oncogene-mediated cell transformation and leukemogenesis, and inhibits the differentiation of AML cells induced by all-trans retinoic acid (ATRA) [38].